OPTION PURCHASE
AGREEMENT
PROGENTIX ORTHOBIOLOGY,
B.V.
The Sellers listed on
Schedule A attached hereto
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
|
CALL AND PUT
OPTIONS
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
2
|
|
|
|
|
1.2
|
|
|
|
|
4
|
|
|
|
|
1.3
|
|
|
|
|
6
|
|
|
|
|
1.4
|
|
|
|
|
6
|
|
|
|
|
1.5
|
|
|
|
|
7
|
|
|
|
|
1.6
|
|
|
|
|
7
|
|
|
|
|
1.7
|
|
|
|
|
8
|
|
|
|
|
1.8
|
|
|
|
|
9
|
|
|
|
|
1.9
|
|
|
|
|
11
|
|
|
|
|
1.10
|
|
|
|
|
12
|
|
|
|
|
1.11
|
|
Time for Determination; Dispute
Mechanism
|
|
|
12
|
|
|
|
|
1.12
|
|
Acknowledgement of Sellers and
Purchaser
|
|
|
14
|
|
|
|
|
1.13
|
|
|
|
|
14
|
|
|
|
|
1.14
|
|
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
REPRESENTATIONS
AND WARRANTIES OF THE SELLERS WITH RESPECT TO THE SELLER
SHARES
|
|
|
14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1
|
|
Authority; Execution and Delivery;
Enforceability
|
|
|
15
|
|
|
|
|
2.2
|
|
|
|
|
15
|
|
|
|
|
2.3
|
|
|
|
|
15
|
|
|
|
|
2.4
|
|
|
|
|
15
|
|
|
|
|
2.5
|
|
|
|
|
16
|
|
|
|
|
2.6
|
|
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
3.
|
|
REPRESENTATIONS
AND WARRANTIES OF THE ACQUIRED COMPANY
|
|
|
16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
Organization and Good Standing
|
|
|
16
|
|
|
|
|
3.2
|
|
|
|
|
16
|
|
|
|
|
3.3
|
|
|
|
|
18
|
|
|
|
|
3.4
|
|
|
|
|
18
|
|
|
|
|
3.5
|
|
|
|
|
18
|
|
|
|
|
3.6
|
|
Title to Properties; Encumbrances
|
|
|
19
|
|
|
|
|
3.7
|
|
Condition and Sufficiency of Assets
|
|
|
19
|
|
|
|
|
3.8
|
|
|
|
|
19
|
|
|
|
|
3.9
|
|
|
|
|
20
|
|
|
|
|
3.10
|
|
No Undisclosed Liabilities
|
|
|
20
|
|
|
|
|
3.11
|
|
|
|
|
20
|
|
|
|
|
3.12
|
|
No Material Adverse Change
|
|
|
22
|
|
|
|
|
3.13
|
|
|
|
|
22
|
|
|
|
|
3.14
|
|
Legal Proceedings; Orders
|
|
|
22
|
|
|
|
|
3.15
|
|
Absence of Certain Changes and Events
|
|
|
23
|
|
|
|
|
3.16
|
|
|
|
|
25
|
|
|
|
|
3.17
|
|
|
|
|
27
|
|
|
|
|
3.18
|
|
|
|
|
28
|
|
-i-
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.19
|
|
|
|
|
29
|
|
|
|
|
3.20
|
|
|
|
|
29
|
|
|
|
|
3.21
|
|
|
|
|
34
|
|
|
|
|
3.22
|
|
Authorizations; Regulatory Compliance
|
|
|
34
|
|
|
|
|
3.23
|
|
Products; Product Liability
|
|
|
35
|
|
|
|
|
3.24
|
|
|
|
|
36
|
|
|
|
|
3.25
|
|
|
|
|
36
|
|
|
|
|
3.26
|
|
Relationships with Affiliates
|
|
|
36
|
|
|
|
|
3.27
|
|
|
|
|
37
|
|
|
|
|
3.28
|
|
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
4.
|
|
REPRESENTATIONS
AND WARRANTIES OF PURCHASER
|
|
|
37
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.1
|
|
Organization and Good Standing
|
|
|
37
|
|
|
|
|
4.2
|
|
|
|
|
37
|
|
|
|
|
4.3
|
|
|
|
|
38
|
|
|
|
|
4.4
|
|
|
|
|
38
|
|
|
|
|
4.5
|
|
|
|
|
38
|
|
|
|
|
4.6
|
|
|
|
|
38
|
|
|
|
|
4.7
|
|
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
5.
|
|
COVENANTS
|
|
|
39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.1
|
|
Notices; Consents; Filings
|
|
|
39
|
|
|
|
|
5.2
|
|
|
|
|
39
|
|
|
|
|
5.3
|
|
|
|
|
40
|
|
|
|
|
5.4
|
|
Notification of Certain Matters
|
|
|
41
|
|
|
|
|
5.5
|
|
Confidentiality; Publicity
|
|
|
41
|
|
|
|
|
5.6
|
|
|
|
|
41
|
|
|
|
|
5.7
|
|
|
|
|
42
|
|
|
|
|
5.8
|
|
Execution of Further Documents
|
|
|
43
|
|
|
|
|
5.9
|
|
|
|
|
43
|
|
|
|
|
5.10
|
|
Right of First Refusal/Right of
Notice
|
|
|
45
|
|
|
|
|
5.11
|
|
Sellers’ Right to Audit Purchaser’s
Net Sales
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
6.
|
|
INDEMNIFICATION; REMEDIES
|
|
|
46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.1
|
|
Survival; Right to Indemnification Not Affected
by Knowledge
|
|
|
46
|
|
|
|
|
6.2
|
|
Indemnification and Payment of Damages by
Sellers
|
|
|
47
|
|
|
|
|
6.3
|
|
Indemnification and Payment of Damages by
Purchaser
|
|
|
48
|
|
|
|
|
6.4
|
|
Limitations on Indemnification
|
|
|
48
|
|
|
|
|
6.5
|
|
|
|
|
49
|
|
|
|
|
6.6
|
|
Procedure for Indemnification—Third Party
Claims
|
|
|
49
|
|
|
|
|
6.7
|
|
Procedure for Indemnification—Other
Claims
|
|
|
50
|
|
|
|
|
6.8
|
|
|
|
|
51
|
|
|
|
|
6.9
|
|
|
|
|
51
|
|
|
|
|
6.10
|
|
|
|
|
51
|
|
-ii-
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.11
|
|
|
|
|
52
|
|
|
|
|
|
|
|
|
|
|
|
|
7.
|
|
CLOSING
CONDITIONS
|
|
|
53
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.1
|
|
Conditions Precedent to Obligations of
Purchaser
|
|
|
53
|
|
|
|
|
7.2
|
|
Conditions Precedent to Obligations of Seller
Parties
|
|
|
55
|
|
|
|
|
|
|
|
|
|
|
|
|
8.
|
|
TERMINATION
|
|
|
56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.1
|
|
|
|
|
56
|
|
|
|
|
8.2
|
|
|
|
|
57
|
|
|
|
|
|
|
|
|
|
|
|
|
9.
|
|
GENERAL
PROVISIONS
|
|
|
57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.1
|
|
|
|
|
57
|
|
|
|
|
9.2
|
|
|
|
|
57
|
|
|
|
|
9.3
|
|
Jurisdiction; Service of Process
|
|
|
59
|
|
|
|
|
9.4
|
|
|
|
|
59
|
|
|
|
|
9.5
|
|
|
|
|
60
|
|
|
|
|
9.6
|
|
Entire Agreement and Modification
|
|
|
60
|
|
|
|
|
9.7
|
|
Assignments, Successors, and No Third-Party
Rights
|
|
|
60
|
|
|
|
|
9.8
|
|
|
|
|
60
|
|
|
|
|
9.9
|
|
|
|
|
61
|
|
|
|
|
9.10
|
|
Section Headings, Construction
|
|
|
61
|
|
|
|
|
9.11
|
|
|
|
|
61
|
|
|
|
|
9.12
|
|
|
|
|
61
|
|
|
|
|
9.13
|
|
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
|
|
10.
|
|
DEFINITIONS
|
|
|
61
|
|
|
|
|
|
***
|
|
Portions of
this page have been omitted pursuant to a request for Confidential
Treatment filed separately with the Commission.
|
-iii-
|
|
|
|
|
|
|
Sellers
Schedule
|
|
|
|
|
|
|
|
Notarial
Deed
|
|
|
|
Purchase
Election Notice
|
|
|
|
Milestone
Completion Notice
|
|
|
|
Form of True-Up
Agreement
|
|
|
|
Manufacturing
Specifications
|
|
|
|
Pre-Clinical
Model
|
|
|
|
Study
Model
|
|
|
|
Patent
Claims
|
|
|
|
Sales Run Rate
Amounts
|
|
|
|
Opinion of
Counsel
|
|
|
|
Form of Escrow
Agreement
|
|
|
|
Founders’
Non-Competition Agreement (Bruijn)
|
|
|
|
Founders’
Non-Competition Agreement (Blitterswijk)
|
|
|
|
Investor
Non-Competition Agreement
|
-iv-
OPTION PURCHASE
AGREEMENT
THIS OPTION
PURCHASE AGREEMENT (“ Agreement ”) is made
as of January 13, 2009 (“ Effective Date
”), by and among NuVasive, Inc., a Delaware corporation
(“ Purchaser ”), Progentix Orthobiology
B.V., a company organized under the laws of the Netherlands (the
“ Acquired Company ”), the shareholders
of the Acquired Company as set forth on Schedule A
attached hereto (each a “ Seller ,” and
collectively, the “ Sellers ,” and along
with the Acquired Company, the “ Seller Parties
”) and Edward van Wezel and Joost D de Bruijn (each, the
“ Sellers’ Representative
”).
Purchaser and the
Seller Parties have entered into a Preferred Stock Purchase
Agreement, dated as of the date hereof (the “ Preferred
Stock Purchase Agreement ”), pursuant to which
Purchaser is purchasing 7,200 ordinary shares €
1.00 par value per share, and 1,600
cumulative preference shares, par value €
1.00 per share, of the Acquired
Company from the Sellers for an aggregate purchase price of
$10,000,000, which shares shall represent immediately after such
issuance, forty percent (40%) of the outstanding capital stock of
the Acquired Company on a fully-diluted basis.
Subject to the
terms and conditions set forth herein, (i) Purchaser may
elect, in its sole discretion, to cause Sellers to sell to
Purchaser all of their issued and outstanding shares of the capital
stock of the Acquired Company held by them representing the
remaining sixty percent (60%) of the outstanding capital stock of
the Company on a fully-diluted basis (the “ Seller
Shares ”) upon delivery of a Purchase Election Notice
(as defined below) to the Sellers’ Representative at any time
between the second anniversary of the Effective Date and the fourth
anniversary of the Effective Date (the “ Call Option
Period ”), and (ii) Purchaser shall be obligated
to purchase from Sellers all of the Seller Shares in the event
(A) the Sellers’ Representative delivers a Milestone
Completion Notice (as defined below) to Purchaser at any time
between the date of this Agreement and the second anniversary of
the Effective Date (the “ Put Option Period
”) or (B) Purchaser’s *** (as defined below) is
greater
than *** at
any time during the Call Option Period. Any purchase of the Seller
Shares by Purchaser shall be referred to herein as an “
Acquisition .” The period from the date of the
Option Agreement through the expiration of the Call Option Period
shall be referred to herein as the “ Option
Period .”
In connection with
this Agreement and the Preferred Stock Purchase Agreement, pursuant
to a notarial deed of amendment to the Acquired Company’s
Articles of Association in the form attached hereto as
Exhibit A (the “ Amended Articles
”), which includes among other things, the creation of
cumulative preference shares A (the “ Series A
Preferred Stock ”) and cumulative preference shares B
(the “ Series B Preferred Stock ”),
and pursuant to the execution of the notarial deed with respect to
the Amended Articles, (i) the cumulative preference shares
held by the Sellers shall be converted into shares of Series A
Preferred Stock, and (ii) the Initial Shares (as defined in
the Preferred Stock Purchase Agreement) purchased by Purchaser
pursuant
|
|
|
|
***
|
|
Portions of
this page have been omitted pursuant to a request for Confidential
Treatment filed separately with the Commission.
|
1
to the
Preferred Stock Purchase Agreement shall be converted into shares
of Series B Preferred Stock, representing, immediately after
such issuance, forty percent (40%) of the outstanding capital stock
of the Acquired Company on a fully-diluted basis (the “
Recapitalization ”). The Acquired Company has
filed a declaration of no-objection with the Dutch Ministry of
Justice with respect to the Amended Articles.
To the extent
applicable, the parties have complied with the provisions of the
Social and Economic Council Merger Regulation ( SER-besluit
Fusiegedragsregels 2000 ) and the Works Council Act ( Wet op
de ondernemingsraden ).
Parties
acknowledge that no notification to the Dutch Competition Authority
( Nederlandse Mededingingsautoriteit ) or any other
competition authority is required for the transaction contemplated
by this Agreement.
The parties,
intending to be legally bound, agree as follows:
1.1
Purchaser’s Call Option .
(a)
Purchaser’s Rights . Purchaser shall have an exclusive
option to acquire, at its sole election and on the terms and
conditions set forth herein, all, but not less than all, of the
Seller Shares, which option may be exercised at any time during the
Call Option Period. In connection therewith, each Seller hereby
grants to Purchaser an exclusive right, exercisable at any time
during the Call Option Period, to acquire all, but not less than
all, of the Seller Shares held by such Seller on the terms set
forth in this Section 1.1 (the “ Call
Option ”).
(b)
Exercise of Call Option .
(i)
Notice . Purchaser may exercise the Call Option by giving
notice, in substantially the form attached hereto as Exhibit
B (the “ Purchase Election Notice ”),
to the Sellers’ Representative (which, in turn, shall deliver
copies of the Purchase Election Notice to each Seller), at any time
during the Call Option Period. The Purchase Election Notice shall
set forth the Purchaser’s calculation of the Initial Purchase
Price (as defined below) and the proposed closing date of the
Acquisition (which shall be the Business Day immediately following
the expiration of the Call Option Review Period (as defined
below)), in each case, subject to the dispute resolution procedures
set forth in Section 1.11 .
(ii)
Disclosure Schedules .
(A) Attached
to this Agreement is a schedule of disclosures and exceptions to
the representations and warranties made by the Seller Parties
pursuant to Section 2 and Section 3 of this
Agreement (the “ Seller Parties Disclosure
Schedule” ). At any time and from time to time during
the Call Option Period, but no more than three (3) times
during the Call Option Period, Purchaser may, upon written notice
to the Sellers’ Representative (a “ Disclosure
Schedule Request ”), require the Seller Parties
to prepare, as if such representations and
2
warranties were
made as of the date of such request, an updated schedule of
disclosures and exceptions to the representations and warranties of
the Seller Parties contained in Section 2 and
Section 3 of the this Agreement (an “
Updated Seller Parties Disclosure Schedule ”),
except to the extent any such representations and warranties refer
expressly to an earlier date. The Acquired Company shall prepare
and deliver to Purchaser an Updated Seller Parties Disclosure
Schedule within ten (10) days of receipt of a Disclosure
Schedule Request by the Sellers’ Representative. Any
Updated Seller Parties Disclosure Schedule delivered pursuant to
this Agreement shall refer only to (1) disclosures of actual
facts contained in the Seller Parties Disclosure Schedule, and
(2) disclosures of actual facts in existence on the date of
such Updated Seller Parties Disclosure Schedule that have occurred
or have been discovered since the Effective Date, and the Updated
Seller Parties Disclosure Schedule shall not otherwise limit or
modify any of the representations and warranties made in this
Agreement. No disclosure of a fact or event on any Updated Seller
Parties Disclosure Schedule shall be deemed to cure any failure to
disclose such fact or event on any previously delivered Seller
Parties Disclosure Schedule or Updated Seller Parties Disclosure
Schedule, or otherwise amend any previously delivered Seller
Parties Disclosure Schedule or Updated Seller Parties Disclosure
Schedule.
(B) Within
ten (10) days after receipt of the Purchase Election Notice,
the Sellers’ Representative shall deliver to Purchaser an
Updated Seller Parties Disclosure Schedule. The Updated Seller
Parties Disclosure Schedule shall refer only to
(1) disclosures of actual facts contained on the Seller
Parties Disclosure Schedule attached to this Agreement, and
(2) disclosures of actual facts in existence on the date of
such Updated Seller Parties Disclosure Schedule that have occurred
or been discovered since the Effective Date of this Agreement, and
the Updated Seller Parties Disclosure Schedule shall specifically
qualify by the existence of the facts or events set forth therein
(but not otherwise limit or modify) any of the representations and
warranties made in this Agreement. No disclosure of a fact or event
on any Updated Seller Parties Disclosure Schedule shall be deemed
to cure any failure to disclose such fact or event on any
previously delivered Seller Parties Disclosure Schedule or Updated
Seller Parties Disclosure Schedule, or otherwise amend any
previously delivered Seller Parties Disclosure Schedule or Updated
Seller Parties Disclosure Schedule. In the event an Updated Seller
Parties Disclosure Schedule is not delivered to Purchaser within
the ten (10) day time period, the most recent Updated Seller
Parties Disclosure Schedule delivered to the Purchaser, or, if
none, the Seller Parties Disclosure Schedule, shall be deemed to be
the final Updated Seller Parties Disclosure Schedule for all
purposes of this Agreement, and all references in this Agreement to
the Updated Seller Parties Disclosure Schedule shall be deemed to
refer to such most recent Updated Seller Parties Disclosure
Schedule or Seller Parties Disclosure Schedule, as
applicable.
(iii)
Review Period . Purchaser shall have a further period of ten
(10) days after receipt of such Updated Seller Parties
Disclosure Schedule to review such Updated Seller Parties
Disclosure Schedule (or if no such Updated Seller Parties
Disclosure Schedule is delivered within the time period specified
in paragraph above, then ten (10) days following the
expiration of such period) (the “ Call Option Review
Period ”), and shall have the right at its election
to rescind its exercise of the Call Option, in its sole discretion,
at any time during the Call Option Review Period by notice to the
Sellers’ Representative (the “ Call Option
Rescission Notice ”), if it is not satisfied in any
manner with its review of such Updated Seller Parties Disclosure
Schedule. In the event that Purchaser delivers a Call Option
Rescission Notice to the
3
Sellers’
Representative within the Call Option Review Period, Purchaser
shall be deemed to have not exercised the Call Option at such time,
and the parties’ respective rights and obligations under this
Agreement shall continue as though no Purchase Election Notice had
been delivered until the expiration of the Call Option Period. In
the event that Purchaser does not deliver a Call Option Rescission
Notice during the Call Option Review Period, the closing of the
Acquisition shall be consummated on the later of (x) the
Business Day immediately following expiration of the Call Option
Review Period in accordance with the terms herein and (y) the
Business Day immediately following the final determination of the
Initial Purchase Price pursuant to Section 1.11
.
1.2
Sellers’ Put Option .
(a)
Purchaser’s Obligations . In the event that the
Acquired Company achieves the Base Milestones (as defined below)
during the Put Option Period, Purchaser shall have an obligation,
subject to Section 1.2(b)(iii) below, to acquire all of
the Seller Shares on the terms and conditions set forth herein (the
“ Put Option ”). In connection therewith,
subject to Section 1.2(b)(iii) , Purchaser shall have a
binding obligation to acquire from each Seller all, but not less
than all, of the Seller Shares held by such Seller on the terms set
forth in this Section 1.2 .
(b)
Exercise of Put Option .
(i)
Notice . The Sellers’ Representative shall exercise
the Put Option and cause Purchaser to consummate the Acquisition by
delivery of a written notice to Purchaser specifying successful
completion of the Base Milestones in the form attached hereto as
Exhibit C (the “ Milestone Completion
Notice ”). The Milestone Completion Notice shall also
set forth the Sellers’ Representative’s calculation of
the Initial Purchase Price (as defined below) and the proposed
closing date of the Acquisition (which shall be the Business Day
immediately following the expiration of the Put Option Review
Period (as defined below) subject to the exceptions set forth in
Section 1.2(b)(iii) below), and in each case, subject
to the dispute resolution procedures set forth in
Section 1.11 .
(ii)
Disclosure Schedules . Along with the Milestone Completion
Notice delivered by the Sellers’ Representative, the
Sellers’ Representative shall deliver to Purchaser an Updated
Seller Parties Disclosure Schedule. The Updated Seller Parties
Disclosure Schedule shall refer only to (A) disclosures of
actual facts contained on the Seller Parties Disclosure Schedule
attached to this Agreement; and (B) disclosures of actual
facts in existence on the date of such Updated Seller Parties
Disclosure Schedule that have occurred or been discovered since the
Effective Date, and the Updated Seller Parties Disclosure Schedule
shall specifically qualify by the existence of the facts or events
set forth therein (but not otherwise limit or modify) any of the
representations and warranties made in this Agreement. No
disclosure of a fact or event on any Updated Seller Parties
Disclosure Schedule shall be deemed to cure any failure to disclose
such fact or event on any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule,
or otherwise amend any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule.
In the event an Updated Seller Parties Disclosure Schedule is not
delivered to Purchaser with the Milestone Completion Notice, the
most recent Updated Seller Parties Disclosure Schedule delivered to
Purchaser, or, if none, the Seller Parties Disclosure
Schedule,
4
shall be deemed
to be the final Updated Seller Parties Disclosure Schedule for all
purposes of this Agreement, and all references in this Agreement to
the Updated Seller Parties Disclosure Schedule shall be deemed to
refer to such most recent Updated Seller Parties Disclosure
Schedule or Seller Parties Disclosure Schedule, as
applicable.
(iii)
Review Period . Purchaser shall have a period of ten
(10) days after receipt of such Updated Seller Parties
Disclosure Schedule to review such Updated Seller Parties
Disclosure Schedule (or if no such Updated Seller Parties
Disclosure Schedule is delivered within the time period specified
in paragraph above, then ten (10) days following the
expiration of such period) (a “ Put Option Review
Period ”), and shall not be obligated to consummate
the Acquisition by notice to the Sellers’ Representative (a
“ Put Option Rescission Notice ”), if
(A) any Seller Parties have materially breached any of the
representations, warranties or covenants set forth in this
Agreement or the Preferred Stock Purchase Agreement or
Purchaser’s rights under the Amended Articles or the Seller
Parties are unable to deliver the certificate required under
Section 7.1(e) hereof, (B) the Acquired Company
has suffered or incurred a Material Adverse Effect, (C) the
Acquired Company is subject to (1) an Action or there is an
Action Threatened involving a claim that any Product infringes the
proprietary rights of a third party, (2) an Action or there is
an Action Threatened involving a claim that any Product has
resulted in personal injury or death to a human patient or
Purchaser in good faith has determined that a Product recall is
required to correct a material defect in any Product, or
(3) an Action or there is an Action Threatened or an
investigation proceeding by any Governmental Body regarding the
conduct of the Acquired Company or involving any Product, or
(D) any of the Sellers breach their non-competition
obligations under the Founders’ Non-Competition Agreements
(as defined in the Preferred Stock Purchase Agreement) or the
Investor Non-Competition Agreement (as defined in the Preferred
Stock Purchase Agreement), Notwithstanding the foregoing, in the
event Purchaser disputes in good faith that the Base Milestones
have not been successfully completed, then Purchaser shall not be
obligated to consummate the Acquisition until the Purchaser and
Sellers resolve the dispute in accordance with
Section 1.11 . In the event that Purchaser delivers a
Put Option Rescission Notice to the Sellers’ Representative
within the Put Option Review Period, Purchaser shall not be
obligated to consummate the Acquisition and Purchaser shall be
entitled, at its sole option, to terminate this Agreement in
accordance with Section 8 herein. In the event that
none of the events described in clause (A),(B),(C), or
(D) have occurred, the closing of the Acquisition shall be
consummated on the later of (x) the Business Day immediately
following expiration of the Put Option Review Period in accordance
with the terms herein and (y) the Business Day immediately
following the final determination of the Initial Purchase Price
pursuant to Section 1.11 , provided that in the event
that Company delivers a Milestone Completion Notice to Purchaser
prior to January 1, 2010, the consummation of the Acquisition shall
not occur until after January 1, 2010, at which time the
consummation of the Acquisition shall occur at a date and time
mutually agreeable to Purchaser and the Sellers’
Representative, which date and time shall be no later than
March 31, 2010.
(iv)
Cure Period . In the event that Purchaser delivers a Put
Option Rescission Notice to the Sellers’ Representative as a
result of any of the events described in clause (A),(B), or (C) in
Section 1.2(b)(iii) above and this Agreement is not
terminated pursuant to Section 1.2(b)(iii) , and the event
which triggered the Put Option Rescission Notice is cured at any
time prior to seven (7) years from the Effective Date of this
Agreement, then the Sellers’
5
Representative
shall notify Purchaser within ten (10) Business Days of such
cure (the “ Cure Notice ”) and shall
deliver to Purchaser an Updated Seller Parties Disclosure Schedule
at such time. Any Updated Seller Parties Disclosure Schedule
delivered pursuant to this Section shall refer only to
(A) disclosures of actual facts contained in the Seller
Parties Disclosure Schedule, and (B) disclosures of actual facts in
existence on the date of such Updated Seller Parties Disclosure
Schedule that have occurred or have been discovered since the date
of this Agreement, and the Updated Seller Parties Disclosure
Schedule shall not otherwise limit or modify any of the
representations and warranties made in this Agreement. No
disclosure of a fact or event on any Updated Seller Parties
Disclosure Schedule shall be deemed to cure any failure to disclose
such fact or event on any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule,
or otherwise amend any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule.
In the event an Updated Seller Parties Disclosure Schedule is not
delivered to Purchaser with the Cure Notice, the most recent
Updated Seller Parties Disclosure Schedule delivered to Purchaser,
or, if none, the Seller Parties Disclosure Schedule, shall be
deemed to be the final Updated Seller Parties Disclosure Schedule
for all purposes of this Agreement, and all references in this
Agreement to the Updated Seller Parties Disclosure Schedule shall
be deemed to refer to such most recent Updated Seller Parties
Disclosure Schedule or Seller Parties Disclosure Schedule, as
applicable. Upon delivery by the Sellers’ Representative of
the Cure Notice and the Updated Seller Parties Disclosure Schedule
to Purchaser, Purchaser shall have an exclusive option (“the
“ Cure Option ”) to acquire, at its sole
election and on the terms set forth in the Milestone Completion
Notice, all, but not less than all, of the Seller Shares within
thirty (30) days of receiving the Cure Notice and the Updated
Seller Parties Disclosure Schedule (the “ Cure Option
Period ”). Purchaser may exercise the Cure Option by
delivering a Purchase Election Notice to the Sellers’
Representative at any time during the Cure Option Period. The
Purchase Election Notice shall set forth the Initial Purchase Price
(as set forth in the Milestone Completion Notice) and the proposed
closing date of the Acquisition (which shall be the Business Day
immediately following the expiration of the Cure Option Period), in
each case, subject to the dispute resolution procedures set forth
in Section 1.11 .
1.3 No
Obligation . Notwithstanding anything to the contrary in this
Agreement, none of the parties hereto shall have any obligation to
consummate the Acquisition unless and until Purchaser delivers a
Purchase Election Notice to the Sellers’ Representative or
the Sellers’ Representative delivers a Milestone Completion
Notice or a Second Put Option Notice (as defined below) to
Purchaser. The parties agree and acknowledge that Purchaser is
under no obligation to deliver any Purchase Election Notice or any
Disclosure Schedule Request at any time.
1.4 Closing
. Subject to the fulfillment or waiver of all of the conditions
contained in Section 7 , on the closing date specified
in the Purchase Election Notice, the Milestone Completion Notice or
the Second Put Option Notice, as the case may be, or, if later, the
Business Day immediately following the final determination of the
Initial Purchase Price pursuant to Section 1.11 , a
closing (the “ Closing ”) will be held at
the offices of DLA Piper Nederland N.V., ‘Meerparc’,
Amstelveenseweg 638, 1081 JJ Amsterdam, the Netherlands (or such
other place as the parties may agree), to the extent required in
the presence of the Notary, and the date of Closing is referred to
herein as the “ Closing Date .” On the
Closing Date, Purchaser and Seller Parties shall cause the
Acquisition to be consummated.
6
1.5 Seller
Shares . Subject to the terms and conditions of this Agreement,
at the Closing, the Notary shall execute the deed of transfer of
the Seller Shares through the notarial deed in the form
substantially attached hereto as Exhibit A .
Immediately thereafter, the Notary shall transfer the Initial
Purchase Price to the Sellers in accordance with the instruction
letter from the Notary.
(a) The
initial purchase price for the Shares will be calculated as set
forth in Section 1.6(b) below (the “ Initial Purchase
Price ”). At the Closing, Purchaser shall transfer an
amount of cash (in United States dollars of immediately available
funds), or common stock, par value $0.001 per share, of Purchaser
(“ Purchaser Common Stock ”), equal to
the Initial Purchase Price minus (i) the Escrow
Amounts, (ii) the Seller Funded Expenses and (iii) the
Loan Amount (the “ Upfront Payment ”) to
the third party account of the Notary in accordance with the
instructions in the Notary Instruction Letter. Prior to the
transfer of the Seller Shares, the Notary shall hold the Upfront
Payment on behalf of Purchaser. After the transfer of the Seller
Shares, the Notary shall hold the Upfront Payment on behalf of the
Sellers. As soon as possible after the Closing, but in any event
within one (1) Business Day of the Closing Date, the Notary
shall pay to Sellers the Upfront Payment, pursuant to the
allocation set forth on Schedule A attached hereto (the
“ Proceeds Allocation ”) and to the bank
accounts or brokerage accounts so indicated by the Sellers. If
there are any changes to the Proceeds Allocation after the
Effective Date, the Sellers’ Representative shall notify
Purchaser within five (5) Business Days of any such changes,
and shall deliver to Purchaser an updated Proceeds Allocation
executed by each of the Sellers (a “ Revised Proceeds
Allocation ”). Unless and until Purchaser receives a
Revised Proceeds Allocation, Sellers shall be bound by the Proceeds
Allocation set forth on Schedule A attached
hereto.
(b) If
Purchaser elects to issue shares of Purchaser Common Stock in
respect of some or all of the Upfront Payment, then:
(i) prior
to such issuance and upon request by Purchaser, (A) Sellers
shall deliver to Purchaser such representations and warranties as
Purchaser shall reasonably request for purposes of exempting the
issuance of such shares from the registration requirements of the
Securities Act and (B) the number of shares of Purchaser
Common Stock to be issued shall be equal to (x) the Upfront
Payment less the amount of any cash transferred to the Notary in
respect of the Initial Purchase Price, divided by (y) the
closing price of the Purchaser Common Stock on the Qualified Stock
Exchange on the Closing Date;
(ii) to
the extent that the Upfront Payment consists of cash and Purchaser
Common Stock, each Seller shall receive the same proportion of cash
and Purchaser Common Stock as each other Seller; and
(iii) at
each Seller’s sole election, Purchaser shall execute the
True-Up Agreement in substantially the form attached hereto as
Exhibit D with respect to the shares of Purchaser
Common Stock issued to each Seller so electing.
(c) The
Initial Purchase Price shall be determined as follows:
7
(i) The
Initial Purchase Price shall be $45,000,000 plus, if applicable,
any amounts payable pursuant to Section 1.6(c)(iii) if
(x) the Sellers’ Representative delivers a Milestone
Completion Notice to the Purchaser during the Put Option Period and
(y) each of the following milestones (each, a “
Base Milestone ,” and collectively, the “
Base Milestones ”) has been achieved by the
Acquired Company on or prior to the date of the Milestone
Completion Notice:
(C) The
Acquired Company has successfully completed ***.
(ii) In
the event Purchaser delivers a Purchase Election Notice to the
Sellers’ Representative during the Call Option Period, the
Initial Purchase Price shall be $35,000,000, and in no event shall
the Purchaser be obligated to pay Sellers any amounts in respect of
the Milestones.
(iii) In
addition to the amounts specified in Section 1.6(c)(i)
, the Initial Purchase Price shall be increased by the following
amounts if, in addition to the Base Milestones, any of the
following milestones (each an “ Additional
Milestone ,” and collectively the “
Additional Milestones ”) has been achieved by
the Acquired Company prior to delivery of the Milestone Completion
Notice. The Base Milestones and the Additional Milestones shall
together be referred to herein as the “
Milestones .”
(A) $5,000,000,
provided the Acquired Company has successfully completed the
***;
(B) $5,000,000,
provided the Acquired Company is issued a patent *** (the “
Patent ”);
(C) $10,000,000,
provided ***, except as provided in Section 5.11
hereof; and
(D) $5,000,000,
provided ****, except as provided in Section 5.11
hereof.
1.7 Milestone
Payments . From and after the Closing Date but prior to the
expiration of the Put Option Period (the “ Post-Closing
Milestone Period ”), in addition to the consideration
set forth in Section 1.6(c) above, in the event that
(x) the Acquired Company has achieved the Base Milestones and
the Sellers’ Representative has delivered a Milestone
Completion Notice, but the Acquired Company has not achieved an
Additional Milestone on the Closing Date, and (y) the Acquired
Company achieves the Additional Milestone during the Post-Closing
Milestone Period, Purchaser shall pay to Sellers the additional
amount payable in respect of such Additional Milestone in cash or,
at Purchaser’s sole election, in shares of Purchaser
Common
|
|
|
|
***
|
|
Portions of
this page have been omitted pursuant to a request for Confidential
Treatment filed separately with the Commission.
|
8
Stock, as set
forth in Section 1.6(b)(iii) (each, a “
Milestone Payment ,” and collectively, the
“ Milestone Payments ”). The Milestone
Payments and the Initial Purchase Price shall be referred to herein
together as the “ Aggregate Purchase Price
.” Upon achieving an Additional Milestone, Purchaser shall
promptly provide written notice to Sellers’ Representative
specifying the Additional Milestone achieved, and Purchaser shall
pay the applicable Milestone Payment to Sellers within ten
(10) Business Days thereof to the bank accounts or brokerage
accounts indicated by the Sellers in accordance with the Proceeds
Allocation, subject in each case, to the dispute resolution
procedures set forth in Section 1.11 . In the event of
a Change of Control of Purchaser, Purchaser agrees to either
(a) cause the acquirer to assume, whether in writing or by
operation of law, all remaining Milestone Payments subject to the
terms and conditions set forth herein or (b) accelerate the
remaining Milestone Payments such that the Milestone Payments
become payable immediately prior to the closing of the Change of
Control transaction.
(a)
Purchaser’s Obligations . From the date of the
expiration of the Put Option Period through the fourth anniversary
of the Effective Date (the “ Second Put Option
Period ”), in the event the Purchaser’s *** is
greater than *** at any time during the Second Put Option Period
(the “ Second Put Option Condition ”),
Purchaser shall be obligated to purchase from Sellers all of the
Seller Shares in accordance with the terms of
Section 1.6(a) for an Initial Purchase Price of
$35,000,000, less (i) the Escrow Amounts, (ii) the Seller
Funded Expenses and (iii) the Loan Amount provided, that at no
time shall Purchaser be required to validate its
*** to
the Sellers, except as provided in Section 5.11 hereof,
and provided further, that in no event shall the Purchaser be
obligated to pay to Sellers any amounts in respect of Milestones
(the “ Second Put Option ”).
(b)
Exercise of Second Put Option .
(i)
Notice . In the event a Second Put Option is triggered,
Purchaser shall notify the Sellers’ Representative of such
event within five (5) Business Days, and thereafter, the
Sellers’ Representative shall have ten (10) Business
Days to exercise the Second Put Option and cause Purchaser to
consummate the Acquisition by delivery of a written notice to
Purchaser by the Sellers’ Representative (“
Second Put Option Notice ”) specifying the
Initial Purchase Price and the date that the closing of the
Acquisition shall be consummated pursuant to
Section 1.8(c) below.
(ii)
Disclosure Schedules . Along with the Second Put Option
Notice delivered by the Sellers’ Representative to Purchaser,
the Sellers’ Representative shall deliver to Purchaser an
Updated Seller Parties Disclosure Schedule. The Updated Seller
Parties Disclosure Schedule shall refer only to
(A) disclosures of actual facts contained on the Seller
Parties Disclosure Schedule attached to this Agreement; and
(B) disclosures of actual facts in existence on the date of
such Updated Seller Parties Disclosure Schedule that have occurred
or been discovered since the Effective Date, and the Updated Seller
Parties Disclosure Schedule shall specifically qualify by the
existence of the facts or events set forth therein (but not
otherwise limit or modify) any of the representations and
warranties made in this Agreement. No
|
|
|
|
***
|
|
Portions of
this page have been omitted pursuant to a request for Confidential
Treatment filed separately with the Commission.
|
9
disclosure of a
fact or event on any Updated Seller Parties Disclosure Schedule
shall be deemed to cure any failure to disclose such fact or event
on any previously delivered Seller Parties Disclosure Schedule or
Updated Seller Parties Disclosure Schedule, or otherwise amend any
previously delivered Seller Parties Disclosure Schedule or Updated
Seller Parties Disclosure Schedule. In the event an Updated Seller
Parties Disclosure Schedule is not delivered to Purchaser with the
Second Put Option Notice, the most recent Updated Seller Parties
Disclosure Schedule delivered to Purchaser, or, if none, the Seller
Parties Disclosure Schedule, shall be deemed to be the final
Updated Seller Parties Disclosure Schedule for all purposes of this
Agreement, and all references in this Agreement to the Updated
Seller Parties Disclosure Schedule shall be deemed to refer to such
most recent Updated Seller Parties Disclosure Schedule or Seller
Parties Disclosure Schedule, as applicable.
(iii)
Review Period . Purchaser shall have a period of ten
(10) days after receipt of such Updated Seller Parties
Disclosure Schedule to review such Updated Seller Parties
Disclosure Schedule (or if no such Updated Seller Parties
Disclosure Schedule is delivered within the time period specified
in paragraph above, then ten (10) days following the
expiration of such period) (a “ Second Put Option
Review Period ”), and shall not be obligated to
consummate the Acquisition by notice to the Sellers’
Representative (a “ Second Put Option Rescission
Notice ”), if (A) any Seller Parties have
materially breached any of the representations, warranties or
covenants set forth in this Agreement or the Preferred Stock
Purchase Agreement or Purchaser’s rights under the Amended
Articles or the Seller Parties are unable to deliver the
certificate required under Section 7.1(e) hereof,
(B) the Acquired Company has suffered or incurred a Material
Adverse Effect, (C) the Acquired Company is subject to (1) an
Action or there is an Action Threatened involving a claim that any
Product infringes the proprietary rights of a third party,
(2) an Action or there is an Action Threatened involving a
claim that any Product has resulted in personal injury or death to
a human patient or Purchaser in good faith has determined that a
Product recall is required to correct a material defect in any
Product, or (3) an Action or there is an Action Threatened or
an investigation proceeding by any Governmental Body regarding the
conduct of the Acquired Company or involving any Product, or
(D) any of the Sellers breach their non-competition
obligations under the Founders’ Non-Competition Agreements
(as defined in the Preferred Stock Purchase Agreement) or the
Investor Non-Competition Agreement (as defined in the Preferred
Stock Purchase Agreement). In the event that Purchaser delivers a
Second Put Option Rescission Notice to the Sellers’
Representative within the Second Put Option Review Period,
Purchaser shall not be obligated to consummate the Acquisition and
Purchaser shall be entitled, at its sole option, to terminate this
Agreement in accordance with Section 8 herein. In the
event that none of the events described in clause (A),(B),(C), or
(D) have occurred, the closing of the Acquisition shall be
consummated on the later of (x) the Business Day immediately
following expiration of the Second Put Option Review Period in
accordance with the terms herein and (y) the Business Day
immediately following the final determination of the Initial
Purchase Price pursuant to Section 1.11 .
(iv)
Second Cure Period . In the event that Purchaser delivers a
Second Put Option Rescission Notice to the Sellers’
Representative as a result of any of the events described in clause
(A),(B), or (C) in Section 1.8(b)(iii) above and
this Agreement is not terminated pursuant to
Section 1.8(b)(iii) , and the event which triggered the
Second Put Option Rescission Notice is cured at any time prior to
seven (7) years from the Effective Date of this Agreement,
then the Sellers’ Representative shall notify Purchaser
within ten (10) Business Days
10
of such cure
(the “ Second Cure Notice ”) and shall
deliver to Purchaser an Updated Seller Parties Disclosure Schedule
at such time. Any Updated Seller Parties Disclosure Schedule
delivered pursuant to this Section shall refer only to
(A) disclosures of actual facts contained in the Seller
Parties Disclosure Schedule, and (B) disclosures of actual
facts in existence on the date of such Updated Seller Parties
Disclosure Schedule that have occurred or have been discovered
since the date of this Agreement, and the Updated Seller Parties
Disclosure Schedule shall not otherwise limit or modify any of the
representations and warranties made in this Agreement. No
disclosure of a fact or event on any Updated Seller Parties
Disclosure Schedule shall be deemed to cure any failure to disclose
such fact or event on any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule,
or otherwise amend any previously delivered Seller Parties
Disclosure Schedule or Updated Seller Parties Disclosure Schedule.
In the event an Updated Seller Parties Disclosure Schedule is not
delivered to Purchaser with the Second Cure Notice, the most recent
Updated Seller Parties Disclosure Schedule delivered to Purchaser,
or, if none, the Seller Parties Disclosure Schedule, shall be
deemed to be the final Updated Seller Parties Disclosure Schedule
for all purposes of this Agreement, and all references in this
Agreement to the Updated Seller Parties Disclosure Schedule shall
be deemed to refer to such most recent Updated Seller Parties
Disclosure Schedule or Seller Parties Disclosure Schedule, as
applicable. Upon delivery by the Sellers’ Representative of
the Second Cure Notice and the Updated Seller Parties Disclosure
Schedule to Purchaser, Purchaser shall have an exclusive option
(the “ Second Cure Option ”) to acquire,
at its sole election and on the terms set forth in the Milestone
Completion Notice, all, but not less than all, of the Seller Shares
within thirty (30) days of receiving the Second Cure Notice
and the Updated Seller Parties Disclosure Schedule (the “
Second Cure Option Period ”). Purchaser may
exercise the Second Cure Option by delivering a Purchase Election
Notice to the Sellers’ Representative at any time during the
Second Cure Option Period. The Purchase Election Notice shall set
forth the Initial Purchase Price (as set forth in the Second Put
Option Notice) and the proposed closing date of the Acquisition
(which shall be the Business Day immediately following the
expiration of the Second Put Option Review Period), in each case,
subject to the dispute resolution procedures set forth in
Section 1.11 .
(a) Subject
to the terms and conditions of this Agreement and the Escrow
Agreement, at the Closing, Purchaser shall deposit in an account
(the “ Escrow Account ”) with U.S. Bank
National Association, or another escrow agent mutually agreeable to
the Purchaser and the Acquired Company, provided such escrow agent
is a bank or trust company organized under the laws of the United
States of America or of the State of New York having (or if such
bank or trust company is a member of a bank company, its bank
holding company shall have) a combined capital and surplus of not
less than $50,000,000 (the “ Escrow Agent
”), out of the Initial Purchase Price, an aggregate of ten
percent (10%) of the Initial Purchase Price plus an amount equal to
$1,500,000 (the “ General Escrow Amount
”) for claims for Damages pursuant to Section 6.2
hereof, which amounts shall be in cash and not shares of Purchaser
Common Stock.
(b) Subject
to the terms and conditions of this Agreement and the Escrow
Agreement, at the Closing, Purchaser shall deposit in the Escrow
Account with the Escrow
11
Agent, out of
the Initial Purchase Price, an aggregate of *** (the “
Special Escrow Amount ,” and together with the
General Escrow Amount, the “ Escrow Amounts
”) for claims for Damages in connection with ***, which
amounts shall be in cash and not shares of Purchaser Common
Stock.
1.10 Notary
. The Sellers are aware that the Notary is a civil law notary
working at DLA Piper Nederland N.V., the firm that advises
Purchaser in respect of the matters set out in this Agreement. With
reference to the Code of Conduct ( Verordening beroeps- en
gedragsregels ) established by the Royal Notarial Professional
Organization ( Koninklijke Notariële Beroepsorganisatie
), parties hereby acknowledge and confirm that (i) the Notary
shall execute any and all deeds related to the Closing Documents;
and (ii) Purchaser is assisted and represented by DLA Piper
Nederland N.V. in relation to the Closing Documents and any other
agreements that may be concluded, or disputes that may arise, in
connection therewith.
1.11 Time for
Determination; Dispute Mechanism .
(a)
Initial Purchase Price . If Purchaser, at any time, objects
to the Sellers determination that a Milestone has been completed,
then Purchaser shall deliver a dispute notice (a “
Pre-Closing Milestone Dispute Notice ”) to the
Sellers’ Representative within fifteen (15) days
following delivery of the Milestone Completion Notice. Purchaser,
on the one hand, and the Sellers’ Representative, on the
other, shall attempt in good faith to resolve any such objections
within fifteen (15) days of the receipt by the Sellers’
Representative of the Pre-Closing Milestone Dispute Notice. If no
Pre-Closing Milestone Dispute Notice is delivered within the
fifteen (15) day time period, then the Initial Purchase Price
specified in the Milestone Completion Notice shall be deemed to be
accepted.
(b)
Milestone Payments. In the event that any Sellers believe
that any Additional Milestone has been achieved during the
Post-Closing Milestone Period, the Sellers’ Representative
shall provide notice of such achievement to Purchaser. If Purchaser
determines in its sole and reasonable discretion that such
Additional Milestone has been achieved during the Post-Closing
Milestone Period, then within thirty (30) days of such notice
from Sellers’ Representative or, if earlier, within thirty
(30) days of Purchaser’s determination that such
Additional Milestone has been achieved, Purchaser shall notify
Sellers’ Representative of its determination and pay to
Sellers the Additional Milestone Payment payable in respect of such
Additional Milestone. If Sellers’ Representative delivers
such a notice and Purchaser determines, in its sole and reasonable
discretion, that the applicable Additional Milestone has not been
achieved, then, within thirty (30) days of Sellers’
Representative’s notice Purchaser shall notify Sellers’
Representative of such determination. If Sellers’
Representative believes that Sellers are entitled to payment of all
or any portion of an Additional Milestone Payment hereunder which
they have not received within thirty (30) days following the
achievement of the Additional Milestone for which payment is due,
Sellers’ Representative may, not later than twelve
(12) months following the achievement of such Additional
Milestone, deliver to Purchaser a notice setting forth
Sellers’ Representative’s determination that all or a
portion of such Additional Milestone Payment is due under this
Agreement (the “ Post-Closing Assessment Notice
”). If Sellers’ Representative does not deliver to
Purchaser a Post-Closing Assessment
|
|
|
|
***
|
|
Portions of
this page have been omitted pursuant to a request for Confidential
Treatment filed separately with the Commission.
|
12
Notice within
such twelve (12) month period, then Sellers shall have been
deemed to agree that the Additional Milestone has not been met and
no payment with respect to such Additional Milestone is due to
Sellers hereunder and Sellers shall have no further rights to such
Milestone Payment or any portion thereof. Such Post-Closing
Assessment Notice may be delivered before or after the expiration
of the Post-Closing Milestone Period without affecting
Sellers’ rights to the applicable Milestone Payment, provided
that that applicable Additional Milestone was actually achieved
prior to the expiration of such Post-Closing Milestone Period. If
Purchaser shall object to Sellers’ determination that a
Additional Milestone has been achieved as set forth in the
Post-Closing Assessment Notice, then Purchaser shall deliver a
dispute notice (a “ Post-Closing Milestone Dispute
Notice ”) to Sellers’ Representative within
fifteen (15) days following Sellers’
Representative’s delivery of the Post-Closing Assessment
Notice. A representative of Purchaser, on the one hand, and the
Sellers’ Representative, on the other, shall attempt in good
faith to resolve any such objections within fifteen (15) days
of the receipt by Sellers of the Post-Closing Milestone Dispute
Notice. If no Post-Closing Milestone Dispute Notice is delivered
within the fifteen (15) day time period, then Sellers’
determination that the Additional Milestone has been achieved, and
that the amount of the Milestone Payment specified in the
Post-Closing Milestone Dispute Notice is due hereunder, shall be
deemed to be accepted and Purchaser shall pay to Sellers those
amounts set forth in the Post-Closing Assessment Notice no later
than five (5) days after the expiration of such fifteen
(15) day time period.
(c)
Second Put Option Condition . If Sellers at any time believe
that the Second Put Option Condition has been satisfied and
Sellers’ Representative has not received a Second Put Option
Notice, the Sellers’ Representative shall deliver a notice of
such achievement to Purchaser no later than thirty (30) days
after the expiration of the Second Put Option Period (the “
Second Put Option Dispute Notice ,” and
together with any Pre-Closing Milestone Dispute Notice and any
Post-Closing Milestone Dispute Notice, a “ Dispute
Notice ”). Purchaser, on the one hand, and the
Sellers’ Representative, on the other, shall attempt in good
faith to resolve within fifteen (15) days of the receipt by
Purchaser of the Second Put Option Dispute Notice whether the
Second Put Option Condition has been satisfied. If Sellers’
Representative fails to deliver the Second Put Option Dispute
Notice within thirty (30) days following the expiration of the
Second Put Option Period, it shall be definitively determined that
the Second Put Option Condition has not been satisfied.
(d)
Dispute Resolution . If Purchaser and Sellers shall be
unable to resolve any such dispute within the fifteen (15) day
period following the non-objecting party’s receipt of a
Dispute Notice, then within five (5) days thereafter,
Purchaser and the Sellers’ Representative shall designate an
arbitrator to resolve any and all matters that remain in dispute
and were properly included in the Dispute Notice. The dispute shall
be resolved by arbitration in New York, New York administered by
the American Arbitration Association in accordance with its
Commercial Arbitration Rules (the “ AAA Rules
”), provided , however , that Purchaser and the
Sellers’ Representative shall agree on the selection of an
independent medical or scientific expert (the “
Independent Expert ”) who will make a report to
the arbitrator which the arbitrator will be required to use as the
basis for his or her decision. In the event that Purchaser and the
Sellers’ Representative are unable to agree on the arbitrator
within such five (5) day period, AAA will have the authority
to select an arbitrator within five (5) Business Days
thereafter. In the event that Purchaser and the Sellers’
Representative are unable to agree on the Independent Expert, the
arbitrator shall have the authority to determine the Independent
Expert. The Sellers’
13
Representative
and Purchaser shall use reasonable efforts to cause the arbitrator
to render a written decision resolving the matters submitted on a
timely basis to the arbitrator within thirty (30) days of the
receipt of such submission. The arbitrator’s decision shall
be based solely on written submissions made on a timely basis by
the Sellers’ Representative and Purchaser and their
respective representatives and not by independent review. The
arbitrator shall address only those items in dispute and may not
assign a value greater than the greatest value for such item
claimed by either party or smaller than the smallest value for such
item claimed by either party. Judgment may be entered upon the
determination of the arbitrator in any court having jurisdiction
over the party against which such determination is to be enforced.
The fees and expenses of the arbitrator incurred pursuant to this
Section 1.11(d) shall be borne by Purchaser and Sellers
(in accordance with their respective Proceeds Allocations), pro
rata, based on the difference between the amount of the Initial
Purchase Price or Milestone Payment (as the case may be), as
finally determined by the arbitrator pursuant to this clause (d),
and the amount of the Initial Purchase Price or Milestone Payment
(as the case may be) asserted by each party in the Milestone
Completion Notice, the Post-Closing Assessment Notice or the Second
Put Option Notice, as the case may be, and the Dispute Notice, as
applicable.
1.12
Acknowledgement of Sellers and Purchaser . Sellers and
Purchaser acknowledge that (i) Purchaser has no obligation to aid
or assist the Acquired Company in order to achieve any Milestone or
to maximize any Milestone, (ii) the parties solely intend the
express provisions of the Closing Documents to govern their
contractual relationship, and (iii) unless and until
Purchaser, at its sole election, issues a Purchase Election Notice,
or unless and until the Sellers’ Representative issues a
Milestone Completion Notice or Second Put Option Notice, Purchaser
is under no obligation to purchase the Seller Shares from Sellers.
The Sellers hereby waive, on their behalf and on behalf of any of
their successors and assigns, any fiduciary duty (but, for
avoidance of doubt, not any implied covenant of good faith and fair
dealing) of Purchaser to Sellers, with respect to the matters
contemplated by this Section 1.12 .
1.13
Withholding. Purchaser shall be entitled to deduct and
withhold from the consideration otherwise payable pursuant to this
Agreement to Sellers such amounts as Purchaser is required to
deduct and withhold under any Tax law, with respect to the making
of such payment. Purchaser shall notify Sellers of the basis for
such withholding no less than fifteen (15) days prior to the
proposed withholding and shall consider in good faith any views of
Sellers with respect to whether such withholding is required under
the United States Internal Revenue Code of 1986 (as amended), or
any provisions of state or local Tax law, with respect to the
making of such payment, provided however, that Sellers provide to
Purchaser such documentation as Purchaser reasonably requests to
support Sellers’ views with respect to whether such
withholding is required.
1.14 Working
Capital. One (1) day prior to the Closing, the
Sellers’ Representative shall deliver to Purchaser a
financial statement setting forth the Working Capital of the
Business on the Closing Date.
|
2.
|
|
REPRESENTATIONS AND WARRANTIES OF
THE SELLERS WITH RESPECT TO THE SELLER SHARES
|
14
Each Seller,
severally but not jointly, hereby represents and warrants to
Purchaser as to such Seller and the Seller Shares owned by such
Seller, as set forth below. Each exception to such representations
and warranties set forth in the Seller Parties Disclosure Schedule
is identified by reference to, or has been grouped under a heading
referring to, a specific section of this Agreement , and the
disclosures in any section or subsection of the Seller Parties
Disclosure Schedule shall qualify other sections and subsections in
this Agreement to the extent it is reasonably apparent from a
reading of the disclosure that such disclosure is applicable to
such other sections and subsections.
2.1 Authority;
Execution and Delivery; Enforceability. Each Seller has full
power, authority and capacity to execute and deliver this Agreement
and to perform such Seller’s respective obligations hereunder
and to consummate the transactions contemplated hereby. This
Agreement has been duly executed and delivered by such Seller and
constitutes the legal, valid and binding obligation of such Seller
enforceable against such Seller in accordance with its terms,
subject to bankruptcy and other similar Legal Requirements of
general applicability relating to or affecting creditors’
rights and to general equity principles.
2.2
Non-Contravention. The execution and delivery of this
Agreement by such Seller does not, and the consummation of the
transactions contemplated hereby and compliance with the terms
hereof, will not (or would not with the giving of notice or the
passage of time):
(a) constitute
a default under or a violation or breach (with or without notice)
of, result in the acceleration of any obligation under, any
provision of any contract or other instrument to which such Seller
is a party or result in the termination or revocation of any
authorization held by such Seller or the Acquired Company necessary
to the ownership of the Seller Shares or the operation of the
business of the Acquired Company;
(b) violate
any Order or any Legal Requirement affecting such Seller;
or
(c) result
in the creation of any Encumbrance on the Seller Shares.
2.3 Title to
Seller Shares. Each Seller is and will be on the Closing Date
the holder and beneficial owner of the Seller Shares owned by such
Seller. The Seller Shares owned by such Seller as of the Effective
Date are as set forth on Part 2.3 of the Seller Parties
Disclosure Schedule. Each Seller has good and valid title to the
Seller Shares owned by such Seller as set forth on Part 0 of the
Seller Parties Disclosure Schedule, free and clear of all
Encumbrances. At the Closing, each Seller will transfer legal and
beneficial, good and valid title to each of the Seller Shares owned
by such Seller, free and clear of all Encumbrances. No Seller is
bound by any contract, agreement, arrangement, commitment or
understanding (written or oral) with, and has not granted any
option or right currently in effect or which would arise after the
Effective Date to, any Person other than Purchaser with respect to
the acquisition of any Seller Shares.
2.4 Consents
and Approvals. Except as set forth in the Seller Parties
Disclosure Schedule, no consent, approval, waiver, license, permit,
order or authorization of, or registration, declaration or filing
with, any Governmental Body, and no consent, approval, waiver or
other similar authorization of any other Person (including, without
limitation, any Person who is a party to a Contract binding on or
affecting the Acquired Company or any Subsidiary), is
required
15
to be obtained
by or on behalf of such Sellers as a result of, or in connection
with, or as a condition of the lawful execution, delivery and
performance of this Agreement or the consummation of the
transactions contemplated hereby.
2.5 Litigation
and Claims. There is no Action pending or, to the Knowledge of
such Seller, Threatened, against or affecting such Seller that
could reasonably be expected to affect such Seller’s ability
to consummate the transactions contemplated hereby.
2.6 No
Finder. Except as set forth in the Seller Parties Disclosure
Schedule, neither such Seller nor any party acting on such
Seller’s behalf has paid or become obligated to pay any fee
or commission to any broker, finder or intermediary for or on
account of the transactions contemplated hereby, and the Acquired
Company will not be liable or obligated in any way whatsoever with
respect to any such fee or commission.
|
3.
|
|
REPRESENTATIONS AND WARRANTIES OF
THE ACQUIRED COMPANY
|
The Acquired
Company hereby represents and warrants to Purchaser as set forth
below. Each exception to such representations and warranties set
forth in the Seller Parties Disclosure Schedule is identified by
reference to, or has been grouped under a heading referring to, a
specific section of this Agreement, and the disclosures in any
section or subsection of the Seller Parties Disclosure Schedule
shall qualify other sections and subsections in this Agreement to
the extent it is reasonably apparent from a reading of the
disclosure that such disclosure is applicable to such other
sections and subsections.
3.1
Organization and Good Standing .
(a) Part 3.1
of the Seller Parties Disclosure Schedule contains a complete and
accurate list for the Acquired Company of its name, its
jurisdiction of incorporation, other jurisdictions in which it is
authorized to do business, and its capitalization (including the
identity of each stockholder and the number of shares held by
each), in each case as of the Effective Date. The Acquired Company
is a corporation duly organized, validly existing, and in good
standing under the laws of its jurisdiction of incorporation, with
full corporate power and authority to conduct its business as it is
now being conducted, to own or use the properties and assets that
it purports to own or use, and to perform all its obligations under
Applicable Contracts. The Acquired Company is a private company
with limited liability duly qualified to do business as a foreign
corporation and is in good standing under the laws of each state or
other jurisdiction in which either the ownership or use of the
properties owned or used by it, or the nature of the activities
conducted by it, requires such qualification, except where the
failure to be so qualified would not reasonably be expected to have
a Material Adverse Effect.
(b) The
Acquired Company made available to Purchaser in the Data Room
copies of the Organizational Documents of the Acquired Company, as
currently in effect.
3.2 Authority;
No Conflict .
(a) The
Closing Documents to which the Acquired Company is a party have
been authorized by the board of directors (“ Board of
Directors ”) of the Acquired Company and, to the
extent required, by the shareholders of the Acquired Company. Upon
the execution and
16
delivery by the
Acquired Company of such Closing Documents, such Closing Documents
will constitute the legal, valid, and binding obligations of the
Acquired Company, enforceable against it in accordance with their
respective terms, subject to bankruptcy and other similar Legal
Requirements of general applicability relating to or affecting
creditor’s rights and to general equity principles. The
execution and delivery of such Closing Documents by the Acquired
Company and the performance of the Contemplated Transactions by it
does not conflict with any provision of the Organizational
Documents of the Acquired Company.
(b) Neither
the execution and delivery of this Agreement nor the consummation
or performance of any of the Contemplated Transactions will,
directly or indirectly (with or without notice or lapse of
time):
(i) contravene,
conflict with, or result in a violation of (A) any provision
of the Organizational Documents of the Acquired Company, or
(B) any resolution adopted by the board of directors or the
shareholders of the Acquired Company;
(ii) contravene,
conflict with, or result in a violation of, or give any
Governmental Body or other Person the right to challenge any of the
Contemplated Transactions or to exercise any remedy or obtain any
relief under, any Legal Requirement or any Order to which the
Acquired Company, or any of the assets owned or used by the
Acquired Company, may be subject;
(iii) contravene,
conflict with, or result in a violation of any of the terms or
requirements of, or give any Governmental Body the right to revoke,
withdraw, suspend, cancel, terminate, or modify, any Governmental
Authorization that is held by the Acquired Company or that
otherwise relates to the business of, or any of the assets owned or
used by, the Acquired Company;
(iv) cause
the Acquired Company to become subject to, or to become liable for
the payment of, any Tax;
(v) cause
any of the assets owned by the Acquired Company to be reassessed or
revalued by any taxing authority or other Governmental
Body;
(vi) contravene,
conflict with, or result in a violation or breach of any provision
of, or give any Person the right to declare a default or exercise
any remedy under, or to accelerate the maturity or performance of,
or to cancel, terminate, or modify, any Applicable Contract;
or
(vii) result
in the imposition or creation of any Encumbrance upon or with
respect to any of the assets owned or used by the Acquired Company,
other than Permitted Encumbrances.
Except as set
forth in Part 3.2 of the Disclosure Schedule the Acquired
Company is not nor will it be required to give any notice to or
obtain any Consent from any Person in connection with the execution
and delivery of this Agreement or the consummation or performance
of any of the Contemplated Transactions.
17
3.3
Capitalization . As of the Effective Date (without giving
effect to the Recapitalization), the authorized equity securities
of the Acquired Company consist of 60,000 ordinary shares, par
value €
1 per share, of which 18,000 shares
are issued and outstanding and 30,000 cumulative preference shares,
par value €
1 per share, of which 4,000 shares
are issued and outstanding. As of the Effective Date, no shares or
classes of the Acquired Company’s capital are reserved for
issuance. No reference to any purported Encumbrance appears in the
shareholders’ register of the Acquired Company. All of the
outstanding equity securities of the Acquired Company have been
duly authorized and validly issued and are fully paid. Except as
set forth in Part 3.3 of the Seller Parties Disclosure
Schedule, as of the Effective Date, there are no Contracts relating
to the issuance, sale, transfer or voting of any issued or issuable
equity securities or other securities (including, but not limited,
to any options, stock appreciation rights, warrants or other
instruments or securities exercisable or exchangeable for, or
convertible into, equity securities) of the Acquired Company. None
of the outstanding equity securities or other securities of the
Acquired Company was issued in violation of any Legal Requirement.
As of the Effective Date, the Acquired Company does not own, nor
does it have any Contract to acquire, any equity securities or
other securities of any Person or any direct or indirect equity or
ownership interest in any other business. As of the Effective Date,
the Acquired Company does not have any Subsidiaries.
3.4 Financial
Statements . The Acquired Company has made available to
Purchaser in the Data Room the unaudited balance sheet of the
Acquired Company and the related unaudited statements of income,
changes in stockholders’ equity, and cash flow balance sheet
of the Acquired Company as of December 31, 2008 (the “
Balance Sheet ”) and the related unaudited
statements of income, changes in shareholders’ equity, and
cash flow for the twelve (12) months then ended (collectively,
the “ Financial Statements ”), including
in each case the notes thereto (except that the unaudited Financial
Statements may not contain all required footnotes and the interim
Financial Statements are subject to year-end adjustments). The
Financial Statements fairly present in all material respects the
financial condition and the results of operations, changes in
stockholders’ equity, and cash flow of the Acquired Company
as at the respective dates of and for the periods referred to in
the Financial Statements. The Financial Statements referred to in
this Section 3.4 reflect the consistent application of
such accounting principles throughout the periods involved, except
as disclosed in the notes to such Financial Statements. No
financial statements of any Person other than the Acquired Company
are required to be included in the consolidated financial
statements of the Acquired Company.
3.5 Books and
Records . The books and records of the Acquired Company, all of
which have been made available to Purchaser in the Data Room, are
complete and correct in all material respects and have been
maintained in accordance with sound business practices in the
Netherlands, including the maintenance of an adequate system of
internal controls. The minute books of the Acquired Company contain
materially accurate and complete records of all meetings held of,
and corporate action taken by, the stockholders, the Board of
Directors and the Supervisory Board of Directors of the Acquired
Company, and no meeting of any such stockholders, Board of
Directors, or committee has been held for which minutes have not
been prepared and are not contained in such minute books. At the
Closing, all of those books and records will be in the possession
of the Acquired Company.
18
3.6 Title to
Properties; Encumbrances . As of the Effective Date, the
Acquired Company does not own (a) any real property,
(b) any leasehold interests or (c) any buildings, plants,
structures and/or equipment. Part 3.6 of the Seller Parties
Disclosure Schedule contains a complete and accurate list as of the
Effective Date of all (A) Assets that the Acquired Company
purports to own, including all of the properties and assets
reflected in the Balance Sheet (except for assets held under
capitalized leases disclosed or not required to be disclosed in
Part 3.6 of the Seller Parties Disclosure Schedule and
personal property sold since the date of the Balance Sheet, as the
case may be, in the Ordinary Course of Business), and (B) all
of the properties and assets purchased or otherwise acquired by the
Acquired Company from the date of the Balance Sheet through the
Effective Date (except for personal property acquired and sold
since the date of the Balance Sheet in the Ordinary Course of
Business and consistent with past practice), which subsequently
purchased or acquired properties and assets (other than inventory
and short-term investments) are listed in Part 3.6 of the
Seller Parties Disclosure Schedule. The Acquired Company is the
sole owner and has good and marketable title (or leasehold title,
as the case may be) to the Assets free and clear of all
Encumbrances, and the Assets reflected in the Balance Sheet are
free and clear of all Encumbrances and are not, in the case of real
property, subject to any rights of way, building use restrictions,
exceptions, variances, reservations, or limitations of any nature
except, with respect to all such properties and assets,
(i) mortgages or security interests shown on the Balance Sheet
as securing specified liabilities or obligations, with respect to
which no default (or event that, with notice or lapse of time or
both, would constitute a default) exists, (ii) mortgages or
security interests incurred in connection with the purchase of
property or assets after the date of the Balance Sheet (such
mortgages and security interests being limited to the property or
assets so acquired), with respect to which no default (or event
that, with notice or lapse of time or both, would constitute a
default) exists, (iii) liens for current taxes not yet due,
(iv) Encumbrances pursuant to the Pledge Agreement or the
Facility Agreement and (v) Encumbrances incurred in the
Ordinary Course of Business, consistent with past practice, or
created by the express provisions of the Contracts, each of the
type identified on Part 3.6 of the Seller Parties Disclosure
Schedule (together, the “ Permitted
Encumbrances ”). All such assets are suitable for the
uses to which they are being put or have been put in the Ordinary
Course of the Business and are in good working order, ordinary wear
and tear excepted.
3.7 Condition
and Sufficiency of Assets . As of the Effective Date, except as
set forth on Part 3.7 of the Seller Parties Disclosure
Schedule, the Assets are all assets of the Acquired Company used in
or related to the processing and manufacturing of the Products.
Xpand Biotechnology B.V., a private company with limited liability
(“ Xpand ”), transferred to the Acquired
Company the Acquired Company Proprietary Rights and prior to such
transfer of the Acquired Company Proprietary Rights, Xpand was the
sole and rightful owner of the Acquired Company Proprietary Rights.
Except as set forth on Part 3.7 of the Seller Parties
Disclosure Schedule, the Assets and the Acquired Company
Proprietary Rights of the Acquired Company constitute all of the
assets, property, real personal or mixed, tangible or intangible,
of the Acquired Company used in or held for use in for the
operation of the Business as presently conducted as of the
Effective Date.
3.8 Accounts
Receivable . As of the Effective Date, the Acquired Company has
no accounts receivable, nor has it previously had any accounts
receivable prior to the Effective Date.
19
3.9
Inventory . As of the Effective Date, the Acquired Company
has no inventory, nor has it previously had any inventory prior to
the Effective Date.
3.10 No
Undisclosed Liabilities . As of the Effective Date, the
Acquired Company has no liabilities or obligations of any nature
(whether known or unknown and whether absolute, accrued,
contingent, or otherwise) except for liabilities or obligations
reflected or reserved against in the Balance Sheet, except for
(a) liabilities or obligations reflected or reserved against
in the Balance Sheet, (b) liabilities or obligations incurred
since the Balance Sheet Date in the Ordinary Course of Business,
(c) liabilities of a type or nature not required to be
reflected in the Financial Statements, which are not material,
individually or in the aggregate, or (d) liabilities or
obligations set forth in Part 3.10 of the Seller Parties
Disclosure Schedule. Except as set forth in Part 3.10 of the
Seller Parties Disclosure Schedule the Acquired Company is not a
guarantor or indemnitor of any Indebtedness of any other
Person.
(a) The
Acquired Company has paid on a timely basis all Taxation that was
due and payable on or before the Closing Date. The unpaid taxes of
the Acquired Company for all Tax periods through the Balance Sheet
Date do not exceed the accruals and reserves for Taxation
(excluding accruals and reserves for deferred Taxation established
to reflect timing differences between book and Tax income) set
forth on the Balance Sheet.
(b) All
notices and returns required to have been given or made, have been
properly and duly submitted by the Acquired Company to the relevant
Governmental Body and all information, notices, computations and
returns submitted to such Governmental Body are true, accurate and
complete and are not the subject of any dispute nor are likely to
become the subject of any dispute with such Governmental Body. The
Acquired Company has not been informed by any Governmental Body
that such Governmental Body formally asserts that the Acquired
Company was required to file any Tax Return that was not filed,
and, to the Sellers’ Knowledge, no such assertion is planned
by any Governmental Body. The Acquired Company has not
(i) waived any statute of limitations with respect to
Taxation, (ii) requested any extension of time within which to
file any Tax Return, or (iii) executed or filed any power of
attorney with any taxing authority. All records that the Acquired
Company is required to keep for Taxation purposes, have been duly
kept and are available for inspection at the Acquired Company
premises.
(c) The
amount of Taxation chargeable to the Acquired Company has not been
affected by any concession, arrangements, agreement or other formal
or informal arrangement with any Governmental Body (not being a
concession, agreement or arrangement available to companies
generally). The Acquired Company is not subject to a special Tax
regime. The Acquired Company is not required to include any amounts
in income, or to exclude any items of deduction in a taxable period
beginning after the Closing Date as a result of: (i) an
instalment sale or open transaction arising in a taxable period
ending on or before the Closing Date; (ii) a prepaid amount
received, or paid, in a taxable period ending on or before the
Closing Date; (iii) deferred gains that could be recognized in
a taxable period ending after the Closing Date; or (iv) any
similar item of deferred income or expense.
20
(d) In
relation to Tax, the Acquired Company has not been subject to and
is not currently subject as of the Effective Date to any
investigation, audit or visit by any Governmental Body, and, to the
Sellers’ Knowledge, no such investigation, audit or visit is
planned by any Governmental Body.
(e) Since
its incorporation through the Effective Date, the Acquired Company
has not been involved in any Taxation controversy and/or litigation
with or against any Governmental Body.
(f) The
Acquired Company has made all deductions and/or withholdings in
respect, or in account, of any Taxation from any payments made by
the Acquired Company that it is obliged or entitled to have made
and has accounted in full to the appropriate authority for all
amounts so deducted and/or withheld.
(g) The
Acquired Company has not received any notice from any Governmental
Body that required or will require the Acquired Company to withhold
Taxation from any payment made since the Balance Sheet Date in
respect of which such withheld Taxation has not been accounted for
in full to the appropriate authority.
(h) The
Acquired Company has not claimed or been granted exemptions from
Taxation that may give rise to the assessment and/or payment of
Taxation in connection with any transactions involving the Acquired
Company, including but not limited to this Agreement,
reorganisations, mergers and/or disposals of the Acquired
Company.
(i) All
applications by the Acquired Company for governmental subsidies,
which have been made or are reflected in the Balance Sheet have
been duly and correctly made and no refunds and no interest,
penalties or additions regarding such refunds are or will be due in
respect of governmental subsidies.
(i) has
always been resident, for Tax purposes, in the
Netherlands;
(ii) is
not and has never been resident, for Tax purposes, in any other
jurisdiction;
(iii) does
not have and has never had a taxable presence outside the
Netherlands; and
(iv) is
not deemed to have and has never been deemed to have had a taxable
presence outside the Netherlands.
(k) No
Taxation, for which any other person or entity is or may be liable,
will be charged in any way to the Acquired Company, and the
Acquired Company is not a party to or bound by any Tax indemnity,
Tax sharing, Tax allocation or similar agreement.
21
(l) Each
transaction between the Sellers or any Affiliate of the Sellers on
the one hand and the Acquired Company on the other hand is and has
been done at an arm’s length basis.
(m) The
Acquired Company is not liable for Taxation imposed on or due by
any third party, including, without limitation, any sub-contractor,
the Sellers or any Affiliate of the Sellers, except to the extent
that full provision has been made in the Financial Statements of
the Acquired Company.
(n) Other
than by their own expiration over time, there is no limitation on
the utilization by the Acquired Company of its net operating
losses, built-in losses, Tax credits or similar items under the Tax
laws of any jurisdiction (other than any such limitations arising
as a result of the consummation of the Contemplated
Transactions).
(o) The
Acquired Company does not own any interest in any entity that is
characterized as a partnership for Tax purposes.
(p) There
are no Tax liens or other Encumbrances with respect to Taxation
upon any of the Assets of the Acquired Company, other than with
respect to Permitted Encumbrances.
(q) The
Acquired Company has delivered or made available to Purchaser in
the Data Room for inspection (i) complete and correct copies
of all Tax Returns of the Acquired Company relating to Taxation and
(ii) complete and correct copies of all documents from any
Governmental Body received by or agreed to by or on behalf of the
Acquired Company relating to Taxation since the Acquired
Company’s formation.
3.12 No
Material Adverse Change . Since the date of the Balance Sheet,
there has not been a Material Adverse Effect.
3.13
Pensions. As of the Effective Date, the Acquired Company has
no, and has never had any retirement benefit schemes, early
retirement schemes, pre-pension schemes or other pension
arrangements, relating to the Business (the “ Pension
Schemes ”), in operation or proposed.
3.14 Legal
Proceedings; Orders .
(a) There
is no pending Proceeding:
(i) that
has been commenced by or against the Acquired Company or that
otherwise relates to or may affect the business of, or any of the
assets owned or used by, the Acquired Company; or
(ii) that
challenges, or that may have the effect of preventing, delaying,
making illegal, or otherwise interfering with, any of the
Contemplated Transactions.
To
Sellers’ Knowledge, (1) no such Proceeding has been
Threatened, and (2) no event has occurred or circumstance
exists that may give rise to or serve as a basis for the
commencement
22
of any such
Proceeding. Seller Parties have made available to Purchaser in the
Data Room copies of all pleadings, correspondence, and other
documents relating to each Proceeding listed in Part 3.14(a) of the
Seller Parties Disclosure Schedule. The Proceedings listed in
Part 3.14(a) of the Seller Parties Disclosure Schedule could
not reasonably be expected to have a Material Adverse
Effect.
(b) There
is no Order to which the Acquired Company, or any of the assets
owned or used by the Acquired Company, is subject.
(c) No
officer, director, agent, or employee of the Acquired Company is
subject to any Order that prohibits such officer, director, agent,
or employee from engaging in or continuing any conduct, activity,
or practice relating to the business of the Acquired
Company.
(d) The
Acquired Company is, and at all times has been, in full compliance
with all of the terms and requirements of each Order to which it,
or any of the assets owned or used by it, is or has been
subject.
(e) No
event has occurred or circumstance exists that may constitute or
result in (with or without notice or lapse of time) a violation of
or failure to comply with any term or requirement of any Order to
which the Acquired Company, or any of the assets owned or used by
the Acquired Company, is subject.
(f) The
Acquired Company has not received, at any time, any notice or other
communication (whether oral or written) from any Governmental Body
or any other Person regarding any actual, alleged, possible, or
potential violation of, or failure to comply with, any term or
requirement of any Order to which the Acquired Company, or any of
the assets owned or used by the Acquired Company, is or has been
subject.
3.15 Absence of
Certain Changes and Events . Except as set forth in
Part 3.15 of the Seller Parties Disclosure Schedule, since the
Balance Sheet Date through the Effective Date, the Acquired Company
has conducted its business only in the Ordinary Course of Business
and none of the following actions or events has
occurred:
(a) any
material loss, damage or destruction to, or any material
interruption in the use of, any of the assets of the Acquired
Company (whether or not covered by insurance) that has had or could
reasonably be expected to have a Material Adverse
Effect;
(b) (i) any
declaration, accrual, set aside or payment of any dividend or any
other distribution in respect of any shares of capital stock of the
Acquired Company, or (ii) any repurchase, redemption or other
acquisition by the Acquired Company of any shares of capital stock
or other securities;
(c) any
sale, issuance or grant, or authorization of the issuance of,
(i) shares or other securities of the Acquired Company,
(ii) any option, warrant or right to acquire any shares or any
other securities of the Acquired Company, or (iii) any
instrument convertible into or exchangeable for shares or other
securities of the Acquired Company;
23
(d) any
amendment or waiver of any of the rights of the Acquired Company
under any share purchase agreement;
(e) any
amendment to any Organizational Document of the Acquired Company,
any merger, consolidation, share exchange, business combination,
recapitalization, reclassification of shares, share split, reverse
share split or similar transaction involving the Acquired
Company;
(f) any
creation of any Subsidiary of the Acquired Company or acquisition
by the Acquired Company of any equity interest or other interest in
any other Person;
(g) any
capital expenditure by the Acquired Company which, when added to
all other capital expenditures made on behalf of the Acquired
Company since the Balance Sheet Date, exceeds €
10,000 in the aggregate;
(h) except
in the Ordinary Course of Business, any action by the Acquired
Company to (i) enter into or suffer any of the assets owned or
used by it to become bound by any Material Contract (as defined in
Section 3.16), or (ii) amend or terminate, or waive any
material right or remedy under, any Material Contract;
(i) any
(i) acquisition, lease or license by the Acquired Company of
any material right or other material asset from any other Person,
(ii) sale or other disposal or lease or license by the
Acquired Company of any material right or other material asset to
any other Person, or (iii) waiver or relinquishment by the
Acquired Company of any right, except for rights or other assets
acquired, leased, licensed or disposed of in the Ordinary Course of
Business;
(j) any
write-off as uncollectible, or establishment of any extraordinary
reserve with respect to, any Indebtedness of the Acquired
Company;
(k) any
pledge of any assets of or sufferance of any of the assets of the
Acquired Company to become subject to any Encumbrance, except for
Permitted Encumbrances and pledges of immaterial assets made in the
Ordinary Course of Business;
(l) any
(i) loan by the Acquired Company to any Person, or
(ii) any incurrence or guarantee of Indebtedness by the
Acquired Company;
(m) any
(i) adoption, establishment, entry into or amendment by the
Acquired Company of any Pension Scheme or (ii) payment of any
bonus or any profit sharing or similar payment to, or material
increase in the amount of the wages, salary, commissions, fringe
benefits or other compensation or remuneration payable to, any of
the directors or officers of the Acquired Company;
(n) any
change of the methods of accounting or accounting practices of the
Acquired Company in any material respect;
(o) any
material Tax election by the Acquired Company;
24
(p) any
commencement or settlement of any Proceeding by the Acquired
Company; and
(q) any
agreement or commitment to take any of the actions referred to in
clauses (c) through (p) above.
3.16 Contracts;
No Defaults .
(a) Part 3.16(a)
of the Seller Parties Disclosure Schedule contains a complete and
accurate list as of the Effective Date, and Seller Parties have
made available to Purchaser in the Data Room true and complete
copies of, each Contract, other instrument or document (including
of any amendments) to which the Acquired Company is a party or by
which its assets are subject or bound:
(i) with
any director, officer or Affiliate of the Acquired
Company;
(ii) evidencing,
governing or relating to Indebtedness;
(iii) not
entered into in the Ordinary Course of Business that involves
expenditures or receipts;
(iv) that
in any way purports to restrict the business activity of the
Acquired Company or any of its Affiliates or to limit the freedom
of the Acquired Company or any of its Affiliates to engage in any
line of business or to compete with any Person or in any geographic
area or to hire or retain any Person;
(v) relating
to the employment of, or the performance of services by, any
employee or consultant, or pursuant to which the Acquired Company
is or may become obligated to make any severance, termination or
similar payment to any current or former employee or director; or
pursuant to which the Acquired Company is or may become obligated
to make any bonus or similar payment (other than payments
constituting base salary) to any current or former employee or
director;
(vi) (A) relating
to the acquisition, transfer, development, sharing or license of
any Proprietary Rights (except for any Contract pursuant to which
(1) any Proprietary Rights is licensed to the Acquired Company
under any third party software license generally available to the
public, or (2) any Proprietary Rights is licensed by the
Acquired Company to any Person on a non exclusive basis); or
(B) of the type referred to in Section 3.20(d)
;
(vii) providing
for indemnification of any officer, director, employee or
agent;
(viii) (A) relating
to the acquisition, issuance, voting, registration, sale or
transfer of any securities, (B) providing any Person with any
preemptive right, right of participation, right of maintenance or
any similar right with respect to any securities, or
(C) providing the Acquired Company with any right of first
refusal with respect to, or right to repurchase or redeem, any
securities;
25
(ix) incorporating
or relating to any guaranty, any warranty or any indemnity or
similar obligation, except for Contracts substantially identical to
the standard forms of end user licenses made available by Seller
Parties to Purchaser in the Data Room;
(x) relating
to any currency hedging;
(xi) (A) imposing
any confidentiality obligation on the Acquired Company or any other
Person, or (B) containing “standstill” or similar
provisions;
(xii) (A) to
which any Governmental Body is a party or under which any
Governmental Body has any rights or obligations, or
(B) directly or indirectly benefiting any Governmental Body
(including any subcontract or other Contract between the Acquired
Company and any contractor or subcontractor to any Governmental
Body);
(xiii) contemplating
or involving the payment or delivery of cash or other consideration
in an amount or having a value in excess of €
5,000 in the aggregate, or
contemplating or involving the performance of services having a
value in excess of €
5,000 in the aggregate;
and
(xiv) any
other Contract, if a breach of such Contract could reasonably be
expected to have a Material Adverse Effect.
(b) Each
of the foregoing is a “ Material Contract
.”
(i) Each
Material Contract is valid and in full force and effect, and is
enforceable against the Acquired Company in accordance with its
terms, subject to bankruptcy and other similar Legal Requirements
of general applicability relating to or affecting creditors’
rights and to general equity principles.
(ii) The
Acquired Company has not violated or breached, or committed any
default under, any Material Contract, except for violations,
breaches and defaults that have not had and would not reasonably be
expected to have a Material Adverse Effect; and, to Sellers’
Knowledge, no other Person has violated or breached, or committed
any default under, any Material Contract, except for violations,
breaches and defaults that have not had and would not reasonably be
expected to have a Material Adverse Effect.
(iii) Except
as set forth on Part 3.16(b) of the Seller Parties Disclosure
Schedule, to Sellers’ Knowledge, no event has occurred, and
no circumstance or condition exists, that (with or without notice
or lapse of time) will or would reasonably be expected to,
(A) result in a violation or breach of any of the provisions
of any Material Contract, (B) give any Person the right to
declare a default or exercise any remedy under any Material
Contract, (C) give any Person the right to receive or require
a rebate, chargeback, penalty or change in delivery schedule under
any Material Contract, (D) give any Person the right to
accelerate the maturity or performance under any Material Contract,
(E) result in the disclosure, release or delivery of the
Acquired Company Source Code, or (F) give any Person the right
to cancel, terminate or modify any Material Contract, except in
each such case for defaults, acceleration rights, termination
rights and other rights that have not had and would not reasonably
be expected to have a Material Adverse Effect.
26
(iv) The
Acquired Company has not received any notice or other communication
regarding any actual or possible violation or breach of, or default
under, any Material Contract, except in each such case for
defaults, acceleration rights, termination rights and other rights
that have not had and would not reasonably be expected to have a
Material Adverse Effect.
(a) Seller
Parties have made available to Purchaser in the Data
Room:
(i) true
and complete copies of all policies of insurance to which the
Acquired Company is a party or under which the Acquired Company, or
any director of the Acquired Company, in his capacity as such, is
or has been covered at any time preceding the date of this
Agreement;
(ii) true
and complete copies of all pending applications for policies of
insurance; and
(iii) any
statement by the auditor of the Acquired Company’s financial
statements with regard to the adequacy of such entity’s
coverage or of the reserves for claims.
(b) The
Acquired Company:
(i) has
no self-insurance arrangements by or affecting the Acquired
Company, including any reserves established thereunder;
(ii) has
not concluded contracts or arrangements, other than a policy of
insurance, for the transfer or sharing of any risk by the Acquired
Company;
(iii) has
made available to Purchaser in the Data Room all obligations of the
Acquired Company to third parties with respect to insurance
(including such obligations under leases and service agreements)
and identifies the policy under which such coverage is provided;
and
(iv) has
not suffered any loss experience or received any claim under any
policy for the current policy year.
(c) All
policies to which the Acquired Company is a party or that provide
coverage to the Acquired Company, or any director or officer of the
Acquired Company in his capacity as such:
(i) are
valid, outstanding, and enforceable;
(ii) are
issued by an insurer that is financially sound and
reputable;
(iii) taken
together, provide adequate insurance coverage for the assets and
the operations of the Acquired Company for all risks normally
insured against by a Person carrying on the same business or
businesses as the Acquired Company;
27
(iv) are
sufficient for compliance with all Legal Requirements and Contracts
to which the Acquired Company is a party or by which any of them is
bound;
(v) will
continue in full force and effect following the consummation of the
Contemplated Transactions; and
(vi) do
not provide for any retrospective premium adjustment or other
experienced-based liability on the part of the Acquired
Company.
(d) The
Acquired Company has not received (A) any refusal of coverage
or any notice that a defense will be afforded with reservation of
rights, or (B) any notice of cancellation or any other
indication that any insurance policy is no longer in full force or
effect or will not be renewed or that the issuer of any policy is
not willing or able to perform its obligations
thereunder.
(e) The
Acquired Company has paid all premiums due, and has otherwise
performed all of its respective obligations, under each policy to
which the Acquired Company is a party or that provides coverage to
the Acquired Company or director thereof.
(f) The
Acquired Company has given notice to the insurer of all claims that
may be insured under any policy provided by such
insurer.
3.18
Environmental Matters .
(a) The
Acquired Company is, and at all times has been, in material
compliance with, and has not been and is not in violation of or
liable under, any Environmental Law. To Sellers’ Knowledge,
there is no actual order, written notice, or other written
communication from, nor has any order, notice, or other
communication been Threatened from (i) any Governmental Body
or private citizen, or (ii) the current or prior owner or
operator of any Facilities, of any actual or potential violation or
failure to comply with any Environmental Law, or of any actual or
Threatened obligation to undertake or bear the cost of any
Environmental, Health, and Safety Liabilities with respect to any
of the Facilities or any other properties or assets (whether real,
personal, or mixed) in which the Acquired Company had an interest,
or with respect to any property or Facility at or to which
Hazardous Materials were generated, manufactured, refined,
transferred, imported, used, or processed by the Acquired Company,
or any other Person for whose conduct they are or may be held
responsible, or from which Hazardous Materials have been
transported, treated, stored, handled, transferred, disposed,
recycled, or received.
(b) There
are no pending or, to Sellers’ Knowledge, Threatened claims,
Encumbrances, or other restrictions of any nature, resulting from
any Environmental, Health, and Safety Liabilities or arising under
or pursuant to any Environmental Law, with respect to or affecting
any of the Facilities or any other properties and assets (whether
real, personal, or mixed) in which the Acquired Company has or had
an interest.
(c) The
Acquired Company has not received, any citation, directive,
inquiry, notice, Order, summons, warning, or other communication
that relates to Hazardous Activity, Hazardous Materials, or any
alleged, actual, or potential violation or failure to comply with
any
28
Environmental
Law, or of any alleged, actual, or potential obligation to
undertake or bear the cost of any Environmental, Health, and Safety
Liabilities with respect to any of the Facilities or any other
properties or assets (whether real, personal, or mixed) in which
the Acquired Company had an interest, or with respect to any
property or facility to which Hazardous Materials generated,
manufactured, refined, transferred, imported, used, or processed by
the Acquired Company, or any other Person for whose conduct they
are or may be held responsible, have been transported, treated,
stored, handled, transferred, disposed, recycled, or
received.
|